InvestorsHub Logo
Followers 31
Posts 6438
Boards Moderated 0
Alias Born 01/20/2016

Re: None

Thursday, 10/13/2016 6:17:10 PM

Thursday, October 13, 2016 6:17:10 PM

Post# of 462218
Quote from Prof. Paul Maruff--listed on the Anavex presentation page for CTAD--"Professor Paul Maruff, Chief Scientific Officer of Cogstate commented: "The Cogstate tests measure people's ability to store and use information. The results of the Phase 2a study demonstrate that ANAVEX 2-73 improves psychomotor function, attention and working memory. For attention and working memory these improvements were statistically significant with a p-value of p<0.05 and p<0.001, respectively and their magnitude clinically important. To my knowledge, we have not yet seen a drug that has improved quantitatively working memory to such an extent as seen with ANAVEX 2-73"--- encouraging !!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News